Evidence map›Paper›PMID 41216400›Full record

ArticleCirculation reports2025

Relationship Between Platelet Aggregation and Clinical Events After Percutaneous Coronary Intervention for Dialysis Patients　- A PENDULUM Analysis Substudy.

Daiki Yoshiura, Masanori Taniwaki, Yoshihisa Nakagawa, Ken Kozuma, Raisuke Iijima, Anna Tsutsui, Yoshitaka Murakami, Masayuki Fukuzawa, Satoru Abe, Go Kato and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daiki YoshiuraDivision of Cardiology, Mitsui Memorial Hospital Tokyo Japan.
Masanori TaniwakiDivision of Cardiology, Mitsui Memorial Hospital Tokyo Japan.
Yoshihisa NakagawaDepartment of Cardiovascular Medicine, Shiga University of Medical Science Shiga Japan.
Ken KozumaDivision of Cardiology, Department of Internal Medicine, Teikyo University Tokyo Japan.
Raisuke IijimaDivision of Cardiovascular Medicine, Toho University Ohashi Medical Centre Tokyo Japan.
Anna TsutsuiDepartment of Medical Statistics, School of Medicine, Toho University Tokyo Japan.
Yoshitaka MurakamiDepartment of Medical Statistics, School of Medicine, Toho University Tokyo Japan.
Masayuki FukuzawaPrimary Medical Science Department, Daiichi Sankyo Co., Ltd. Tokyo Japan.
Satoru AbePrimary Medical Science Department, Daiichi Sankyo Co., Ltd. Tokyo Japan.
Go KatoPrimary Medical Science Department, Daiichi Sankyo Co., Ltd. Tokyo Japan.
Masato NakamuraDivision of Cardiovascular Medicine, Toho University Ohashi Medical Centre Tokyo Japan.
Kengo TanabeDivision of Cardiology, Mitsui Memorial Hospital Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with endstage kidney disease undergoing hemodialysis (HD) have higher risks of ischemic and bleeding events after percutaneous coronary intervention (PCI). However, the association between high platelet reactivity (HPR) and clinical events in dialysis patients remains unclear. This post hoc analysis of the PENDULUM registry examined the relationships of HPR with major adverse cardiac and cerebrovascular events (MACCE) and major bleeding in dialysis patients. Methods and Results: Based on P2Y Conclusions: HPR was not associated with increased risks of MACCE and major bleeding in dialysis patients.

Indexed as

DialysisDual antiplatelet therapyHigh platelet reactivityPercutaneous coronary intervention

Identifiers

PMID41216400
PMCPMC12597243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.